Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688336's Days Inventory is ranked worse than 64.11% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:688336: 262.94
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.63.
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sunshine Guojian Pharmaceutical (Shanghai) Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sunshine Guojian Pharmaceutical (Shanghai) Co Days Inventory Related Terms
Sunshine Guojian Pharmaceutical (Shanghai) Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Guojian Pharmaceutical (Shanghai) Co Days Inventory Chart
Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
SHSE:688336 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Guojian Pharmaceutical (Shanghai) Co Days Inventory vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Days Inventory of 296.25 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. This is 21% below median its historical median of 373.81. Over the past decade, Sunshine Guojian Pharmaceutical (Shanghai) Co's Days Inventory has ranged from 254.59 to 701.71. According to the industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #409 out of 638 companies in the Biotechnology industry, placing it in the top 64.1%.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Days Inventory too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Days Inventory of 296.25 is 21% below median its 10-year median of 373.81. Over the past 10 years, this metric has ranged from a low of 254.59 to a high of 701.71. The Biotechnology industry median Days Inventory is 183.20. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 296.25 is 61.7% above this industry median. Based on the distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #409 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #409 out of 638 companies for Days Inventory. This places Sunshine Guojian Pharmaceutical (Shanghai) Co in the lower half of its industry. The industry median Days Inventory is 183.20. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 296.25 is 61.7% above this benchmark. Historically, Sunshine Guojian Pharmaceutical (Shanghai) Co's own Days Inventory has ranged from 254.59 to 701.71 over the past decade. While the company's 10-year median is 373.81 vs. the industry median of 183.20, Sunshine Guojian Pharmaceutical (Shanghai) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Days Inventory of 296.25 is 61.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Days Inventory is 296.25, which is 21% below median its own 10-year median of 373.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Possible Value Trap. The stock's GF Value™ is ¥67.25, compared to a current price of ¥43.96 — trading 34.6% below its estimated fair value. The current Days Inventory is 296.25, which is 21% below median its 10-year median of 373.81 and 61.7% above the Biotechnology industry median of 183.20. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Days Inventory is 296.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued.
The current stock price of ¥43.96 is trading 34.6% below its estimated GF Value™ of ¥67.25.
GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Possible Value Trap.
Key valuation signals for SHSE:688336:
Days Inventory: 296.25 (21% below median its 10-year median of 373.81)
GF Value™: ¥67.25 vs. price of ¥43.96 (34.6% below fair value)
Industry Position: 61.7% above the Biotechnology median (#409 of 638)
No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
81GF Score
Get the complete analysis for SHSE:688336
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688336 has been successfully added to your 
